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Abstract
Puberty is a critical age for patients with Turner syndrome (TS): infertility is reported to be linked to karyotype and
spontaneous puberty and menarche occur in approximately 30% of patients, especially in mosaicism. However, it is
not always predictable considering hormonal pattern and pelvic transabdominal ultrasound scan (US).
The aim of the study is to compare the accuracy of Magnetic Resonance Imaging (MRI) and US to evaluate uterine
and gonads volume, to visualize the presence of follicles and to predict spontaneous puberty and menarche in girls
with TS. In a retrospective study, we evaluated 19 TS patients (age: 9–16 years), who underwent transabdominal
pelvic US and pelvic MRI as required by parents. We correlated pelvic imaging with karyotype, hormonal data and
pubertal outcome, and we compared US resolution to MRI.
MRI revealed a higher accuracy in the study of uterus and ovaries, and permitted to measure ovaries not visualized
by US. Ovarian volume, the presence of follicles and the occurrence of spontaneous puberty were not related to
the karyotype; spontaneous puberty started in one patient with a karyotype 45,X and in two patients with mosaicism
(45,X/46,XX; 47,XXX/45, X). Ovarian follicles were relieved by MRI in patients with a spontaneous menarche and the
persistence of menstrual cycles correlated with an ovarian volume corresponding to Tanner stage 3–4. We stress the
role of MRI in the follow-up of TS adolescents, guide in the choice of the timing of treatment.
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Dear Sir,
TS is the most common chromosomal aneuploidy in
humans, with a prevalence of 1:2.500 females. However
the real incidence in pregnancies is significantly higher,
because 99% of foetuses with a 45,X karyotype under-
goes to spontaneous abortion [1].
TS is characterized by a typical phenotype, associated
with total or partial X chromosome monosomy, some-
times with mosaicism. Typical facies, hearth and kidney
malformations, short stature and hypogonadism are
characteristic. Secondary sexual characters and menses
are reached in TS patients by oestroprogestinic treat-
ment. However, an optimal timing and dose of the
oestroprogestinic treatment does not guarantee uterine
growth until the adult volume [2, 3]. Otherwise
spontaneous puberty and menarche occur without
oestroprogestinic treatment in 30% of TS patients. This
favourable prognosis is described especially in mosai-
cism; however, it is not always predictable by karyotype,
hormonal pattern and pelvic scan [4, 5].
Transabdominal pelvic US and pelvic MRI are accurate,
safe and non-invasive techniques for visualizing the size
and the shape of the internal genitalia in pre-pubertal and
pubertal girls. US provides a quicker and accurate check
up of gonads and uterus, however MRI provides measure-
ments that are less operator-dependent [6].
Usually, ovary and uterine diameters are evaluated by
transabdominal scan in TS adolescents [4]. However, US
has lower sensitivity and specificity compared to laparos-
copy, especially in streak gonads. Only one study [7]
described the results of pelvic MRI imaging in TS. MRI
showed a higher sensitivity and specificity for evaluation
of ovarian follicles and uterus and a higher accuracy to
predict spontaneous puberty and menarche.
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The objectives of our study are to compare the accur-
acy of MRI vs US to evaluate uterine and gonads vol-
ume; to visualize follicles and to predict spontaneous
puberty and menarche in our patients; to highlight the
role of MRI in the follow-up of TS adolescents and in
the choice of treatment line and timing.
We present a retrospective study on the evaluation and
follow up, over a 6 years period, of 19 patients with TS, di-
agnosed by karyotype. Patients age was: 9–16 years; bone
age (by Greulich and Pyle method) was: 12.4 ± 2.2 years;
all the patients underwent transabdominal pelvic US and
pelvic MRI, as required by parents. We compared ovarian
and uterine size, follicles number and volume evaluated by
transabdominal US vs by MRI and we correlated pelvic
imaging with karyotype and hormonal data (FSH, LH;
Prolactin, TSH, fT3, fT4, IGF-1).
In all the patients a standard karyotype was obtained
by lymphocytes culture of peripheral blood and revealed
the following karyotypes: 45,X in 7 patients; 45,X/46,XX
in 1; 45,X/47,XXX in 1; 45,X/46,XY in 1; deletion of the
short arm of X chromosome in 1; 45,X/46 del(Xp) mo-
saicism in 1; mosaicism 45,X/46,X,i(Xq) in 4; mosaicism
45,X/46,X,r(X) in 3.
All the patients received or are currently treated with GH
(0.03–0.04 mg/kg/day) with a significant improvement of
growth. Three patients developed hypothyroidism second-
ary to autoimmune thyroiditis and received L-thyroxine
with an adequate normalization of the hormonal pattern.
None developed Celiac disease during the follow up. Two
patients had kidney malformations, with no impairment of
the renal function. None had cardiac malformations with
hemodynamic significance. Six patients were treated with
transdermal oestrogens or with 17β-oestradiol plus proges-
terone, with a regular menstrual bleeding.
Three patients had a spontaneous puberty and menar-
che, reached without oestrogens and still have regular
menses. Transabdominal pelvic US was realized by a
3.5–5 MHz probe. We evaluated uterine and ovarian size,
as well as the presence and number of ovarian follicles.
MRI was conducted without contrast, with spin-echo
(SE), FAST-SE, T1 and T2-weighted images in axial, cor-
onal and sagittal sections. All the patients were studied
by the same experienced specialist in radiology.
The pelvis was scanned in a 1.5 TL in axial, coronal
and sagittal planes (Philips 1.5 TL), high performance
4-channels body phased array coils. T1w, T2/TSE/SPIR,
DW1 sequences were performed. T1w and T2w sequences,
the best choice to study ovaries, were performed with slice
thickness of 5 mm. T2w sequence, considered the gold
standard to study uterus and gonads, was performed
also with slice thickness of 3–4 mm in patients with a
hypoplastic uterus. MRI defined the following uterine
measurements (see Table 4): TD; APD; fundus/cervix
ratio; endometrial thickness. Furthermore, MRI defined:
right ovarian volume; left ovarian volume; right ovarian
TD; left ovarian TD; right ovarian APD; left ovarian APD.
Uterine and ovarian volumes were calculated using the
following formula: Volume (ml) = LD (cm) x TD (cm) x
APD (cm) × 0,5233 [7]. The fundus/cervix ratio was cal-
culated by dividing the longitudinal diameters of the
corpus with the longitudinal diameter of the cervix.
As reference of the physiological uterine and ovarian
size we considered the population of healthy girls
described in the work of K. Holm et al. [8] (see Table 1).
We have obtained consent to publish from the partici-
pant (or legal parent or guardian for children) to report
individual patient data.
Hormonal parameters are summarized in Table 2.
US and MRI measurements are summarized in
Tables 3 and 4, respectively.
The fundus/cervix ratio detected by MRI was higher
(1.55 ± 0.54) than the ratio measured by US
(1.39 ± 0.50). The endometrial thickness was detected in
11/19 patients (58%), while endometrium was not visible
in the remaining 8. The ovarian APD detected by MRI
was not significantly different than the ovarian LD mea-
sured by US; however, in two patients, ovaries were visu-
alized by MRI and not by US. The ovarian volume and
the follicles number were not related to karyotype
(mosaicism or 45,X); 3 patients showed a spontaneous
start and progression of puberty: one with 45,X; two
with mosaicism (45,X/46, XX; 47,XXX/45, X). The pres-
ence of ovarian follicles was relieved by MRI in patients
with a spontaneous menarche and the persistence of
menstrual cycles, and it was correlated with an ovarian
volume > 7 cm (see Fig. 1).
Gonadotropins levels, especially FSH, were nega-
tively correlated with US and MRI measurements of
uterine and ovarian size, without reaching the statis-
tical significance. Besides FSH and LH showed an in-
verse correlation with fundus/cervix ratio measured
by US and by MRI; FSH and LH maintained an inverse
correlation with endometrial thickness, confirmed by
Table 1 Uterus and ovaries US measurements in relation to breast
development, in healthy girls (from “Holm K, Laursen EM, Brocks V,
Müller J: Pubertal maturation of the internal genitalia: an ultrasound
evaluation of 166 healthy girls. Ultrasound in Obstetrics and
Gynecology 1995;6,175-181”, modified)
Uterine US measurements:
Median (range)
Uterine
volume (ml)
Ovarian
volume (ml)
B1 1.6 (07–7.9) 1.2 (0.5–5.1)
B2 2.8 (1.3–8.1) 2.2 (1–4.6)
B3 8 (2–18) 4.1 (1.9–8.6)
B4 37 (11–56) 6.2 (1.3–28)
B5 43 (12–82) 7.3 (1.9–23)
≥19 years 61 (37–130) 7.6 (2.9–37)
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lower levels of gonadotropins in patients with spon-
taneous menarche.
MRI revealed a higher definition of imaging for uterus
and ovaries, defining volume and morphology, follicular
volume, endometrial thickness, uterine body/neck ratio
(see Fig. 2).
The endometrial thickness was measured with a higher
precision by MRI than by US.
Puberty is a critical age for patients with TS, with
problems related to possible spontaneous puberty and
menarche, to oestrogen induction and progression of
puberty, and to future fertility.
We did not find a direct correlation between karyotype
and spontaneous menarche and/or puberty. The karyo-
type of the patients with spontaneous puberty and/or
menarche varied from 45,X to mosaicism.
Transabdominal pelvic US is an accurate, low cost and
widely available technique [8]. In a routine pelvic im-
aging follow up of TS patients, US is the universally
available and suitable recommended technique. Never-
theless, US has a low reproducibility especially if re-
peated by different radiologists. However, as previously
evidenced [7], MRI has a higher definition of uterus and
ovaries volume and morphology; in fact, it shows a
higher sensitivity in the measurement of uterus and
ovaries volumes, and in the recognition of follicles and
in the evidence and measurement of endometrial thick-
ness. In our study, in fact, MRI showed ovaries in two
patients, otherwise not detected by US. The ovaries im-
aging well correlates with gonadotropins levels, both in
patients with spontaneous or induced pubertal develop-
ment. Furthermore, ovaries volume and spontaneous pu-
berty does not correlate with karyotype in our patients.
MRI can help in the study of ovaries and shows a
higher sensitivity in their evaluation, when they are be-
hind the uterus, when bladder is empty, when meteor-
ism is present. MRI is the best choice to follow TS
patients with mosaicism including Y or fragments of Y
chromosome. In fact, this karyotype is a risk factor of
dysgerminoma in dysgenic gonads [9].
MRI in T2w (in sagittal, coronal and axial planes) has
a higher definition than US when the uterus is hypoplas-
tic. MRI could represent a future gold standard in the
follow up of adolescent patients with TS: in fact, it is
able to view small ovaries and follicles otherwise not
found by transabdominal pelvic US.
However, we must consider the significantly higher
costs of MRI compared to US and the difficulties to
repeat the exam frequently in patients who need a
follow-up, as TS girls. In younger patients the diffi-
culties to perform MRI are often linked to the need
to do a sedation of the patient; for this reason, we
organized MRI only for patients who did not require
a sedation.
Therefore, we suggest performing MRI almost in pu-
bertal age and comparing MRI with US measurements
and hormonal data. The evidence of well defined ovaries,
associated with normal levels of FSH, LH, oestradiol
could be a favourable prognostic element of spontaneous
puberty. The follow-up can be assured by US, monitor-
ing the efficacy of treatment and the timing of addiction
of progesterone to oestrogens.
Table 2 Hormonal parameters
FSH 25.74 ± 38.76 mIU/ml
LH 4.07 ± 4.46 mIU/ml
Prolactin 9.86 ± 5.76 ng/ml
IGF-1 364.9 ± 206.5 ng/ml
Table 3 uterus and ovaries US measurements in TS
Uterine US measurements M SDS Range
LD 4.33 1.92 2.00–8.13
Corpus 2.55 1.45 1.00–5.42
Collus 1.70 0.56 1.00–2.71
Fundus/Cervix 1.39 0.50 1.00–2.00
Right ovarian LD (ml) 2.6 0.1 2.4–2.70
Left ovarian LD (ml) 2.77 0.45 1.87–3.20
Table 4 uterus and ovaries MRI measurements in TS
Uterine MRI measurements M SDS Range
TD 2.32 1.32 0.60–4.30
APD 2.05 1.17 0.50–3.60
Corpus 2.83 1.52 0,90–5.00
Collus 1.79 0.69 0.60–3.00
Fundus/cervix 1.55 0,54 1.00–2.50
endometrial thickness 6.90 3.90 3.00–16.00
Right ovarian volume (ml) 3.16 3.44 1.3–8.3
Left ovarian volume (ml) 5.40 4.10 2.5–8.3
Right ovarian TD (mm) 1.48 0.43 1.00–2.00
Left ovarian TD (mm) 1.3 0.14 1.20–1.40
Right ovarian APD (mm) 2.23 0.76 1.30–3.10
Left ovarian APD (mm) 2.55 1.34 1.60–3.50
Fig. 1 MRI imaging of a patient with spontaneous menarche
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However, MRI can integrate the endocrine follow-up,
help to distinguish patients with potential spontaneous
pubertal maturation and to choose the appropriate time
to begin estrogens treatment, avoiding unnecessary
drugs. MRI is a useful guide in the choice of drugs and
of their correct management timing in the follow-up of
TS adolescents. These findings can improve the follow-
up of these patients and select those with a prognosis of
possible fertility [10].
In addition, MRI could be a milestone in the diagnosis
and identification of TS patients who are candidate to
ovary cortex biopsy.
These critical points require a multidisciplinary ap-
proach, with still open questions on the endocrine and
psychological follow-up of TS patients.
Abbreviations
APD: Anteroposterior diameter; LD: Longitudinal diameter; MRI: Magnetic
resonance imaging; SE: Spin-echo; TD: Transverse diameter; TS: Turner
syndrome; US: Ultrasound scan
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Fig. 2 US and MRI immaging in a patient with hypoplastic uterus
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